Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-23T00:13:26.841Z Has data issue: false hasContentIssue false
  • English
  • Français

Heat stroke during treatment with olanzapine, trihexyphenidyl, and trazodone in a patient with schizophrenia

Published online by Cambridge University Press:  27 October 2015

Chin-Pang Lee ,
Pei-Jung Chen  and
Chia-Ming Chang
Chin-Pang Lee
Affiliation:
Department of Psychiatry, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Pei-Jung Chen
Affiliation:
Department of Psychiatry, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Chia-Ming Chang*
Affiliation:
Department of Psychiatry, Chang Gung Memorial Hospital, Taoyuan, Taiwan School of Medicine, Chang Gung University, Taoyuan, Taiwan
*
Chia-Ming Chang, Department of Psychiatry, Chang Gung Memorial Hospital, Linkou branch No. 5, Fusing Street, Gueishan, Taoyuan 33305, Taiwan. Tel: +886 3 3281200, ext. 3836; Fax: +886 3 3280267; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

Heat stroke is a medical emergency. Psychiatric patients are particularly susceptible to heat stroke. Therefore, awareness and preventive measures of heat stroke are important for both clinicians and patients.

Case description

A 49-year-old man with schizophrenia, who was under maintenance treatment with olanzapine 20 mg/day, trihexyphenidyl 4 mg/day, and trazodone 50 mg/day, suffered from heat stroke in a heat wave and required intensive care. He recovered with the medical treatment provided.

Discussion

Several factors could have contributed to the impaired thermoregulation and the occurrence of heat stroke in this case: schizophrenia, the psychotropic regimen, and lack of preventive measures. Possible differential diagnoses of heat stroke in this case include infection, neuroleptic malignant syndrome, and serotonin syndrome.

Conclusion

Heat stroke can occur during the maintenance treatment of olanzapine, trihexyphenidyl, and trazodone for schizophrenia. Clinicians should be proactive to reduce the risk of heat stroke in psychiatric patients.

Keywords

anticholinergicheat strokeolanzapineschizophreniatrazodone
Type
Case Report
Information
Acta Neuropsychiatrica , Volume 27 , Supplement 6 , December 2015 , pp. 380 - 385
Copyright
© Scandinavian College of Neuropsychopharmacology 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Bouchama, A, Knochel, J. Heat stroke. N Engl J Med 2002;346:1978–1988.CrossRefGoogle ScholarPubMed
2. Duthie, D. Heat-related illness. Lancet 1998;352:1329–1330.CrossRefGoogle ScholarPubMed
3. Shahid, M, Hatle, L, Mansour, H, Mimish, L. Echocardiographic and Doppler study of patients with heatstroke and heat exhaustion. Int J Cardiac Imaging 1999;15:279–285.CrossRefGoogle ScholarPubMed
4. Reilly, TH, Kirk, MA. Atypical antipsychotics and newer antidepressants. Emerg Med Clin North Am 2007;25:477–497.CrossRefGoogle ScholarPubMed
5. Hermesh, H, Shiloh, R, Epstein, Y, Manaim, H, Weizman, A, Munitz, H. Heat intolerance in patients with chronic schizophrenia maintained with antipsychotic drugs. Am J Psychiatry 2000;157:1327–1329.CrossRefGoogle ScholarPubMed
6. Chong, TWH, Castle, DJ. Layer upon layer: thermoregulation in schizophrenia. Schizophr Res 2004;69:149–157.CrossRefGoogle ScholarPubMed
7. Shiloh, R, Weizman, A, Stryjer, R, Kahan, N, Waitman, DA. Altered thermoregulation in ambulatory schizophrenia patients: a naturalistic study. World J Biol Psychiatry 2009;10:163–170.CrossRefGoogle ScholarPubMed
8. Bark, N. Deaths of psychiatric patients during heat waves. Psychiatr Serv 1998;49:1088– 1090.CrossRefGoogle ScholarPubMed
9. Ramos, MJG, Valverde, FMG, Álvarez, CS, Katnich, LO, Quirante, FP. Fatal heat stroke in a schizophrenic patient. Case Rep Crit Care 2012;2012:1–5.CrossRefGoogle Scholar
10. Kao, RL, Kelly, LM. Fatal exertional heat stroke in a patient receiving zuclopenthixol, quetiapine and benztropine. Can J Clin Pharmacol 2007;14:e322–e325.Google Scholar
11. Kerwin, RW, Osborne, S, Sainz-Fuertes, R. Heat stroke in schizophrenia during clozapine treatment: rapid recognition and management. J Psychopharmacol 2004;18:121–123.CrossRefGoogle Scholar
12. Thara, R. Heat stroke and schizophrenia. Indian J Psychiatry 1998;40:395–396.Google ScholarPubMed
13. Clapham, JC. Central control of thermogenesis. Neuropharmacology 2012;63:111–123.CrossRefGoogle ScholarPubMed
14. Hayes, BD, Martinez, JP, Barrueto, F Jr. Drug-induced hyperthermic syndromes. Emerg Med Clin North Am 2013;31:1019–1033.CrossRefGoogle ScholarPubMed
15. Boulant, JA. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 2000;31:S157–S161.CrossRefGoogle ScholarPubMed
16. Balthazar, CH, Leite, LH, Ribeiro, RM, Soares, DD, Coimbra, CC. Effects of blockade of central dopamine D1 and D2 receptors on thermoregulation, metabolic rate and running performance. Pharmacol Rep 2010;62:54–61.CrossRefGoogle ScholarPubMed
17. Balthazar, CH, Leite, LH, Rodrigues, AG, Coimbra, CC. Performance-enhancing and thermoregulatory effects of intracerebroventricular dopamine in running rats. Pharmacol Biochem Behav 2009;93:465–469.CrossRefGoogle ScholarPubMed
18. Bhanushali, M, Tuite, P. The evaluation and management of patients with neuroleptic malignant syndrome. Neurol Clin 2004;22:389–411.CrossRefGoogle ScholarPubMed
19. Central Weather Bureau. Monthly Data for 2012/07. Ministry of Transportation and Communication R.O.C, 2012. Retrieved 29 September 2014 from http://www.cwb.gov.tw/V7e/climate/monthlyData/mD.htm.Google Scholar
20. Intergovernmental Panel on Climate Change. Climate change 2007. In: Solomon S, Qin D, Manning M, Chen Z, Marquis M, Averyt K, et al., editors. The physical science basis (English). Cambridge, UK: Cambridge University Press, 2007. 996 pp.CrossRefGoogle Scholar
21. Kilbourne, EM, Choi, K, Jones, TS, Thacker, SB. The Field Investigation Team. Risk factors for heatstroke: a case control study. JAMA 1982;247:3332–3336.CrossRefGoogle Scholar
22. Bouchama, A, Dehbi, M, Mohamed, G, Matthies, F, Shoukri, M, Menne, B. Prognostic factors in heat wave-related deaths. Arch Intern Med 2007;167:2170–2176.CrossRefGoogle ScholarPubMed
23. Naranjo, CA, Busto, U, Sellers, EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245.CrossRefGoogle ScholarPubMed
24. Stahl, S. Stahl’s essential psychopharmacology: neuroscientific basis and practical applications. Cambridge Medicine. ISBN: 9781107025981. Cambridge University Press, 2013.Google Scholar
25. Kreuzer, P, Landgrebe, M, Wittmann, M et al. Hypothermia associated with antipsychotic drug use: a clinical case series and review of current literature. J Clin Pharmacol 2012;52:1090–1097.CrossRefGoogle ScholarPubMed
26. Longmore, J, Banjar, W, Szabadi, E, Bradshaw, CM. Antagonism of phenylephrine-evoked sweating by trazodone and amitriptyline in humans in vivo. Br J Clin Pharmacol 1987;23:245–246.CrossRefGoogle ScholarPubMed
27. Kassahun, K, Mattiuz, E, Nyhart, JE. Disposition and biotransformation of the antipsychotic agent olanzapine in humans. Drug Metab Dispos 1997;25:81–93.Google ScholarPubMed
28. Bergemann, N, Frick, A, Parzer, P, Kopitz, J. Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients. Pharmacopsychiatry 2004;37:63–68.Google ScholarPubMed
29. Jafferany, M, Lowry, J. Case report of olanzapine-associated elevation of serum creatine kinase in a 16-year-old boy with heat stroke. Prim Care Companion J Clin Psychiatry 2008;10:250–252.CrossRefGoogle Scholar
30. Kontaxakis, VP, Havaki-Kontaxaki, BJ, Christodoulou, NG, Paplos, KG. Olanzapine-associated neuroleptic malignant syndrome. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:897–902.CrossRefGoogle ScholarPubMed
31. Levenson, JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137–1145.Google ScholarPubMed
32. Kuo, CJ, Yang, SY, Liao, YT et al. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophr Bull 2013;39:648–657.CrossRefGoogle ScholarPubMed
33. Maddalena, AS, Fox, M, Hofmann, M, Hock, C. Esophageal dysfunction on psychotropic medication. Pharmacopsychiatry 2004;37:134–138.Google ScholarPubMed
Supplementary material: File

Lee supplementary material

Table

Download Lee supplementary material(File)
File 44.6 KB